Efficacy of Ericksonian Hypnosis in the Management of Chronic Pain Related to Parkinson's Disease (DOLHYP-PARK-1)

University Hospital, Lille

Status

Enrolling

Conditions

Chronic Pain

Parkinson Disease

Treatments

Behavioral: Erickson hypnosis

Study type

Interventional

Funder types

Other

Identifiers

NCT04259203

2019-A00539-48 (Other Identifier)

2018-51

Details and patient eligibility

About

This study evaluates the efficacity of Erickson hypnosis in the treatment of chronic pain in patients with Parkinson's disease. Half of participants will follow a 2-month Erickson hypnosis protocole, while the other half will benefit from the usual care.

Full description

A large proportion of patients with Parkinson's disease suffer of chronic pain directly related to the disease. The management of painful symptoms is difficult and currently, there is no commonly admitted guidelines.

Several studies have shown the efficacy of Erickson hypnosis to reduce the perception of chronic pain in different conditions. This efficacy has never been tested in Parkinson's disease.

The objective of this study is to assess the efficacy of Erickson hypnosis protocol, compared to usual care, for the management of Parkinson's disease-related chronic pain.

The study team assume that Erickson hypnosis will be more efficient than usual care to reduce perceived chronic pain. They also assume that regular practice of autohypnosis will contribute to long-term efficacy.

Enrollment

76 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Men or women
18 to 80 years old
idiopathic Parkinson's disease
without neurological co-morbidity
Suffering from chronic pain (for at least 3 months), related to Parkinson's disease
Having a pain intensity of at least 30 mm on the VAS (average intensity over the previous week) for Parkinson's disease-related pain
antiparkinsonian, analgesic and psychotropic treatments stable for 1-month
having a health insurance
signed informed consent form

Exclusion criteria

Patient with a neurological condition other than Parkinson's disease or with an atypical Parkinson's syndrome
Early untreated patient
Patient with acute intercurrent pain
Patient whose pain is mainly attributable to another pathology (rheumatoid arthritis, spondyloarthritis ankylosing, diabetic neuropathy, cancer, etc.)
Patient with cognitive impairment objectified by a score at the Montreal Cognitive Assessment (MoCA) <24
Patient with hallucinations and/or psychosis (MDS-UPDRS 1.2> 1)
Patient with a apathy (MDS-UPDRS 1.5> 1)
Patient with disabling dyskinesia (MDS-UPDRS) 4.1 AND 4.2> 1)
Patient under the protection of adults
Pregnant or lactating woman